The prognosis and management of inactive HBV carriers

Federica Invernizzi, Mauro Viganò, Glenda Grossi, Pietro Lampertico

Research output: Contribution to journalArticle

Abstract

Patients with chronic hepatitis B virus (HBV) infection lacking the serum hepatitis B e antigen (HBeAg) and with antibodies against HBeAg (anti-HBe), are the prevalent subgroup of HBV carriers worldwide. The prognosis of these patients is different from inactive carriers (ICs), who are characterized by persistently normal serum alanine aminotransferase (ALT) and low (

Original languageEnglish
Pages (from-to)100-104
Number of pages5
JournalLiver International
Volume36
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Hepatitis B e Antigens
Hepatitis B virus
Chronic Hepatitis B
Virus Diseases
Serum
Alanine Transaminase
Antibodies

Keywords

  • Antiviral treatment
  • HCC
  • Hepatitis B virus
  • Inactive carriers
  • Natural history
  • Prophylaxis

ASJC Scopus subject areas

  • Hepatology

Cite this

The prognosis and management of inactive HBV carriers. / Invernizzi, Federica; Viganò, Mauro; Grossi, Glenda; Lampertico, Pietro.

In: Liver International, Vol. 36, 01.01.2016, p. 100-104.

Research output: Contribution to journalArticle

Invernizzi, Federica ; Viganò, Mauro ; Grossi, Glenda ; Lampertico, Pietro. / The prognosis and management of inactive HBV carriers. In: Liver International. 2016 ; Vol. 36. pp. 100-104.
@article{93621c1368f547529ef55168a2c9b00b,
title = "The prognosis and management of inactive HBV carriers",
abstract = "Patients with chronic hepatitis B virus (HBV) infection lacking the serum hepatitis B e antigen (HBeAg) and with antibodies against HBeAg (anti-HBe), are the prevalent subgroup of HBV carriers worldwide. The prognosis of these patients is different from inactive carriers (ICs), who are characterized by persistently normal serum alanine aminotransferase (ALT) and low (",
keywords = "Antiviral treatment, HCC, Hepatitis B virus, Inactive carriers, Natural history, Prophylaxis",
author = "Federica Invernizzi and Mauro Vigan{\`o} and Glenda Grossi and Pietro Lampertico",
year = "2016",
month = "1",
day = "1",
doi = "10.1111/liv.13006",
language = "English",
volume = "36",
pages = "100--104",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - The prognosis and management of inactive HBV carriers

AU - Invernizzi, Federica

AU - Viganò, Mauro

AU - Grossi, Glenda

AU - Lampertico, Pietro

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Patients with chronic hepatitis B virus (HBV) infection lacking the serum hepatitis B e antigen (HBeAg) and with antibodies against HBeAg (anti-HBe), are the prevalent subgroup of HBV carriers worldwide. The prognosis of these patients is different from inactive carriers (ICs), who are characterized by persistently normal serum alanine aminotransferase (ALT) and low (

AB - Patients with chronic hepatitis B virus (HBV) infection lacking the serum hepatitis B e antigen (HBeAg) and with antibodies against HBeAg (anti-HBe), are the prevalent subgroup of HBV carriers worldwide. The prognosis of these patients is different from inactive carriers (ICs), who are characterized by persistently normal serum alanine aminotransferase (ALT) and low (

KW - Antiviral treatment

KW - HCC

KW - Hepatitis B virus

KW - Inactive carriers

KW - Natural history

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84952837774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952837774&partnerID=8YFLogxK

U2 - 10.1111/liv.13006

DO - 10.1111/liv.13006

M3 - Article

VL - 36

SP - 100

EP - 104

JO - Liver International

JF - Liver International

SN - 1478-3223

ER -